 |
Biostar Pharmaceuticals, Inc.
OTCBB: BSPM
Recommendation: STRONG BUY
12 Mo. Price Target: $9.13 |
|
FEATURED REPORT |
 |
Huifeng
Bio-Pharmaceutical Technology, Inc
OTCBB: HFGB
Rating: Spec Buy
12 Mo. Price target is $2.37 |
|
FEATURED REPORT |
 |
SkyPeople Fruit
Juice, Inc.
AMEX: SPU
Rating: BUY
12 mo.
Price Target: $13.29 |
|
FEATURED REPORT |
|
|
Welcome
to
EquityNet Research. Here
you will find a frequently updated list of the latest equity research, reviews
and news you need to know when searching for stocks and company information. If
you haven't done so already, take a minute to subscribe to our
Monthly Report
and Update Alerts!
EquityNet Research was formed in January 1999 to provide the investing public
with professional, independent, objective research on under-followed public
companies.
|
 |

|
Is Analyst Coverage Necessary?
Take a look at these facts:
-
70.9% in an Investopedia.com survey said that "a company that hires a legitimate
fee-based research firm is making a positive statement about its investment
potential."
-
According to a survey by Charles Schwab & Co. reported in the NY
Times, an astonishing 78% of active stockholders now "value research from
independent firms over analysis by Wall Street firms with financial ties to the
companies they are rating..."
So why is independent research so important? It is much more than simply telling the story from an outside pair of eyes (though it does that). Independent research provides a benchmark by which potential investors can gauge a company's fair value, eliminating such extraneous factors as wars, political uncertainty, market-maker manipulation, etc. And perhaps most importantly, it is a statement by management to current shareholders and investors that, "We have the confidence in our business model to pay an independent analyst to perform a fair, accurate valuation on our stock. Not only do we not have anything to hide, we are sure the market will share our enthusiasm once all the facts are elicited."
 |
BUYSIDE Magazine
March 2005
While some issuer-paid research firms keep their analysts on an independent
contractor basis, Sherman Oaks, CA based EquityNet Research has revolved around
the idea that the principals of the company think a stock is worth covering,
it's worth them covering it on their own.... |
|
 |
|
|
|
|
|
Regence Invests in Kinetix Living Corp. (PR Newswire)
Wed, 10 Mar 2010 22:05:00 Etc/GMT
-
As part of its continued focus on developing programs designed to meet employers' needs, Regence has acquired the assets of Kinetix Living Corp., a Seattle-based company that provides customized health and nutrition programs to corporate clients and individuals throughout the country.
|
Maveron-Backed Health and Wellness Company Kinetix Acquired by Regence BlueShield (Business Wire)
Wed, 10 Mar 2010 22:05:00 Etc/GMT
-
SEATTLE----Maveron LLC, a Seattle-based venture capital firm focused on helping exceptional entrepreneurs build great consumer businesses, announced the asset acquisition of portfolio company Kinetix Living Corp. by Regence BlueShield of Washington.
|
International Merchant Advisors to Complete Purchase of Medical Marijuana Company Organic Science, Inc. (PR Newswire)
Wed, 10 Mar 2010 21:52:00 Etc/GMT
-
International Merchant Advisors, Inc. www.imaiinc.com announced today that the company is preparing to complete the purchase of medical marijuana management and development company Organic Science, Inc. Organic Science, Inc. is intended to become the primary operating subsidiary of IMAI in this business segment, and is focused on the implementation of Organic's plans for acquisition and development of medically supervised Wellness Centers and medical marijuana clinics in selected markets throughout the USA. International Merchant Advisors agreement to purchase Organic Science is subject to a valuation from an independent third party, and CEO Mel Roseman offered this update on its progress, "We believe that the valuation will meet or exceed our expectations, and anticipate closing on the purchase of Organic Science.
|
Semtech Announces Fourth Quarter of Fiscal Year 2010 Results (Business Wire)
Wed, 10 Mar 2010 21:30:00 Etc/GMT
-
CAMARILLO, Calif.----SEMTECH CORPORATION , a leading supplier of high performance analog and mixed-signal semiconductors, today reported un-audited financial results for the fourth quarter of fiscal year 2010 that ended January 31, 2010.
|
|
|